DK0972782T3 - Monoklonalt antistof, der genkender oligosaccharidet N-glycolyleret galactose-glucose-sialinsyre i maligne tumorer, og præparater, der indeholder det - Google Patents

Monoklonalt antistof, der genkender oligosaccharidet N-glycolyleret galactose-glucose-sialinsyre i maligne tumorer, og præparater, der indeholder det

Info

Publication number
DK0972782T3
DK0972782T3 DK99903581T DK99903581T DK0972782T3 DK 0972782 T3 DK0972782 T3 DK 0972782T3 DK 99903581 T DK99903581 T DK 99903581T DK 99903581 T DK99903581 T DK 99903581T DK 0972782 T3 DK0972782 T3 DK 0972782T3
Authority
DK
Denmark
Prior art keywords
glycolylated
oligosaccharide
galactose
glucose
monoclonal antibody
Prior art date
Application number
DK99903581T
Other languages
Danish (da)
English (en)
Inventor
Perez Adriana Lacret Entr Carr
Herrera Zaima Mazorra
Molina Luis Enrique Fernandez
Lopez Ana Maria Vazquez
Sierra Ailette Mulet
Rodriguez Rolando Perez
Original Assignee
Centro Inmunologia Molecular
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro Inmunologia Molecular filed Critical Centro Inmunologia Molecular
Application granted granted Critical
Publication of DK0972782T3 publication Critical patent/DK0972782T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK99903581T 1998-02-05 1999-02-05 Monoklonalt antistof, der genkender oligosaccharidet N-glycolyleret galactose-glucose-sialinsyre i maligne tumorer, og præparater, der indeholder det DK0972782T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU1998022A CU22731A1 (es) 1998-02-05 1998-02-05 Anticuerpo monoclonal que reconoce el oligosacárido ácido siálico n´glicolilado-galactosa-glucosa (ngcneu-gal-glu) en tumores malignos y composiciones farmacéuticas que los contienen
PCT/CU1999/000001 WO1999040119A1 (fr) 1998-02-05 1999-02-05 Anticorps monoclonal reconnaissant l'oligosaccharide acide sialique n-glycolyle-galactose-glucose dans les tumeurs malignes et sa composition

Publications (1)

Publication Number Publication Date
DK0972782T3 true DK0972782T3 (da) 2004-02-02

Family

ID=5459215

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99903581T DK0972782T3 (da) 1998-02-05 1999-02-05 Monoklonalt antistof, der genkender oligosaccharidet N-glycolyleret galactose-glucose-sialinsyre i maligne tumorer, og præparater, der indeholder det

Country Status (17)

Country Link
US (1) US6429295B1 (fr)
EP (1) EP0972782B1 (fr)
JP (1) JP4125383B2 (fr)
CN (1) CN1149224C (fr)
AR (1) AR013021A1 (fr)
AT (1) ATE250085T1 (fr)
AU (1) AU764632B2 (fr)
BR (1) BR9904773A (fr)
CA (1) CA2286288C (fr)
CO (1) CO4810341A1 (fr)
CU (1) CU22731A1 (fr)
DE (1) DE69911322T2 (fr)
DK (1) DK0972782T3 (fr)
ES (1) ES2209391T3 (fr)
MX (1) MXPA99009082A (fr)
PT (1) PT972782E (fr)
WO (1) WO1999040119A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020122795A1 (en) * 2000-12-08 2002-09-05 Paller Amy S. Compositions containing gangliosides for use in the treatment of skin disorders
CU23007A1 (es) * 2001-04-06 2004-12-17 Ct De Inmunologia Molecular Ct De Inmunologia Mole Combinaciones inmunoterapéuticas para el tratamiencombinaciones inmunoterapéuticas para el tratamiento de tumores que sobre-expresan gangliósidos to de tumores que sobre-expresan gangliósidos
US20040115204A1 (en) * 2002-12-11 2004-06-17 Fanger Gary R. Antibodies to treat cancer
EP1587408A4 (fr) * 2002-12-20 2007-09-05 Momenta Pharmaceuticals Inc Marqueurs de glycane utilises dans le diagnostic et la surveillance d'une maladie
CU23403A1 (es) * 2003-04-23 2009-08-04 Centro Inmunologia Molecular Anticuerpos recombinantes y fragmentos que reconocen el gangliósido n-glicolil gm3 y su uso para diagnóstico y tratamiento de tumores
CU23297A1 (es) * 2004-11-16 2008-07-24 Ct De Inmunologa A Molecular Formulaciones inmunoterapã0/00uticas para la inducciã"n de autoanticuerpos bloqueadores de la uniã"n de interleucina-2 a su receptor. su uso en el tratamiento del cã ncer
CN101835319B (zh) 2009-03-13 2014-05-07 奥斯兰姆有限公司 用于电子镇流器的外壳
PT2552959T (pt) 2010-03-26 2017-04-21 Memorial Sloan Kettering Cancer Center Anticorpos para muc16 e métodos de utilização dos mesmos
WO2012075173A2 (fr) 2010-12-01 2012-06-07 Board Of Regents The University Of Texas System Compositions et procédé de désimmunisation de protéines
WO2012106368A2 (fr) 2011-01-31 2012-08-09 The Regents Of The University Of California Procédés d'inhibition du cancer de la prostate
CU24070B1 (es) 2011-12-27 2015-01-29 Ct De Inmunología Molecular Composiciones farmacéuticas para el tratamiento de tumores que expresan regf y gangliósidos n-glicolilados gm3 (neugcgm3)
CU24120B1 (es) 2012-03-01 2015-08-27 Ct De Inmunología Molecular Anticuerpos recombinantes con especificidad dual por los gangliósidos n-acetil gm3 y n-glicolil gm3
CN104651314B (zh) * 2015-02-14 2018-06-19 百泰生物药业有限公司 获得高产稳定表达细胞克隆的方法及由此获得的抗体分子
BR112017019978A2 (pt) 2015-03-17 2018-06-19 Memorial Sloan Kettering Cancer Center anticorpo ou um fragmento de ligação com antígeno, conjugado, receptor de antígeno, cadeia, conjugado de cadeia, proteína de fusão, célula t, polinucleotídeo, vetor, célula ex vivo, método para produzir uma cadeia, método para produzir um anticorpo, composição farmacêutica, método para tratamento de câncer, glicopeptídeo, método para gerar um anticorpo
US10722523B2 (en) 2015-03-17 2020-07-28 The Regents Of The University Of California Chemoimmunotherapy for epithelial cancer
CN109721632B (zh) * 2017-10-27 2023-10-31 齐鲁制药有限公司 一种高纯度神经节苷脂gm1及其制备方法
CU20210104A7 (es) 2021-12-21 2023-07-12 Ct Inmunologia Molecular Proteínas de fusión compuestas por un anticuerpo y una muteína agonista de interleucina 2

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965198A (en) * 1985-12-24 1990-10-23 Konica Corporation Monoclonal antibody and method of manufacturing hybridoma producing the same
CA2066433A1 (fr) * 1990-07-10 1992-01-11 Haruo Matsuda Hybridome specifique du poulet produisant l'immunoglobuline g
ES2166770T3 (es) 1993-12-09 2002-05-01 Centro Inmunologia Molecular Anticuerpos monoclonales contra gangliosidos y sus utilizaciones en la inmunoterapia activa especifica de tumores malignos.

Also Published As

Publication number Publication date
US6429295B1 (en) 2002-08-06
JP2001509684A (ja) 2001-07-24
CN1149224C (zh) 2004-05-12
AU2407899A (en) 1999-08-23
WO1999040119A1 (fr) 1999-08-12
WO1999040119A9 (fr) 2000-07-06
CO4810341A1 (es) 1999-06-30
CU22731A1 (es) 2002-02-28
DE69911322T2 (de) 2004-07-01
ES2209391T3 (es) 2004-06-16
AU764632B2 (en) 2003-08-28
EP0972782A1 (fr) 2000-01-19
JP4125383B2 (ja) 2008-07-30
BR9904773A (pt) 2000-03-21
DE69911322D1 (de) 2003-10-23
PT972782E (pt) 2004-02-27
EP0972782B1 (fr) 2003-09-17
CA2286288A1 (fr) 1999-08-12
CN1256696A (zh) 2000-06-14
CA2286288C (fr) 2010-09-28
AR013021A1 (es) 2000-11-22
MXPA99009082A (es) 2002-04-24
ATE250085T1 (de) 2003-10-15

Similar Documents

Publication Publication Date Title
DK0972782T3 (da) Monoklonalt antistof, der genkender oligosaccharidet N-glycolyleret galactose-glucose-sialinsyre i maligne tumorer, og præparater, der indeholder det
NO20004657D0 (no) Kredittkort-system og -fremgangsmÕte
NO20021105L (no) Transaksjonskort
DK0965578T3 (da) Hidtil ukendt triglycerik og præparat, som omfatter dette
IS8950A (is) Einklóna mótefni gegn CTLA-4 úr manni.
NO20011216D0 (no) Azetidinderivater, fremstilling og medisiner inneholdende disse
NO20006449D0 (no) Betalingssystem
NO20013777D0 (no) Fremgangsmåte for gjennomföring av ikke kontant betaling og system for gjennomföring av fremgangsmåten
NO922155D0 (no) Peptid og antistoffer som inhiberer integrin-ligandbinding
TR200000747A3 (tr) Fermuar sürgüsü.
DK0988861T3 (da) Stabiliserede proteinpræparater
EP1246686A4 (fr) Identification rapide de proteines a l'aide de melanges d'anticorps
NO20003662L (no) Syntetiske polysakkarider, fremgangsmÕte for fremstilling derav og farmasøytiske preparater inneholdende slike
NO960925D0 (no) Diagnostiske, prognostiske og terapeutiske metoder for faste, ikke-lymfoide tumorer og deres metastaser
WO1997029199A3 (fr) Peptides pour l'antigene prostatique specifique et leurs utilisations
DE3584280D1 (de) Monoklonaler antikoerper gegen menschlichen krebs.
EP1016717A4 (fr) Nouvelle proteine ayant une excellente expression dans le cancer du sang, gene codant cette proteine, anticorps dirigee contre cette derniere et procede de detection de l'expression de cette proteine
DK1192163T3 (da) Dithiepino[6,5-b]pyriner, beslægtede præparater og fremgangsmåder
NO20000079D0 (no) Ancrod spesifikke monoklonale antistoff, antistoff- fragmenter, blandinger, derivater og anvendelse derav
ES1032815Y (es) Disposicion perfeccionda de cierre en carros de supermercado o similares.
TR199902750A3 (tr) Anti-p53 monoklonal antikorlar ve kullanimlari.
IT1296687B1 (it) Chiusura regolabile, in particolare per cinturino da orologio, e procedimento per il suo ottenimento.
DK1107793T3 (da) Dextran-leptin-konjugater, farmaceutiske præparater og relaterede fremgangsmåder
DK199800263U3 (da) Betalingskortterminal
ES1039209Y (es) Tarjeta magnetica perfeccionada.